Skip to main content

Abstract

Bleomycin (BLM) is an antitumor antibiotic produced by a strain of Streptomyces verticillus (1). Clinically employed bleomycin (Blenoxane) is a mixture of 11 active components. Of these, bleomycin A2 (BLM A2) , 1(2), is the most abundant, accounting for 55-70% (w/w) of the mixture. Bleomycin is of value in the treatment of squamous cell carcinomas, lymphomas, and testicular carcinomas (3,4). The mechanism of action of bleomycin is not understood. Most of the early efforts as well as those in progress have focused on the interaction of bleomycin, most often bleomycin A2 , with DNA. The glycolpeptide is capable of 11 active components. Of these, bleomycin A2 (BLM A2 ) , 1(2), is the most abundant, accounting for 55-70% (w/w) of the mixture. Bleomycin is of value in the treatment of squamous cell carcinomas, lymphomas, and testicular carcimixture prevents DNA breakage. It is known that these metal ions complex to bleomycin and in so doing apparently inactivate the drug.

The online version of the original chapter can be found at http://dx.doi.org/10.1007/978-1-4612-6191-9_10

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. H. Umezawa, K. Maeda, T. Takeuchi, and Y. Akami, J. Antibiot, (Tokyo), Ser. A., 19, 200 (1969).

    Google Scholar 

  2. A new structure for bleomycin and related antibiotics was proposed by Drs. Umezawa and Takita during the symposium.

    Google Scholar 

  3. H. Umezawa, Biomedicine, 18, 459 (1973).

    PubMed  CAS  Google Scholar 

  4. R.H. Blum, S.K. Carter, and K.A. Agre, Cancer, 31, 903 (1973).

    Article  PubMed  CAS  Google Scholar 

  5. L.F. Povirk, W. Wiibker, W. Kohnlein, and F. Hutchinson, Nucl. Acid Res.,4, 3573 (1977).

    Article  CAS  Google Scholar 

  6. C.W. Haidle, Mol. Pharmacol., 7, 645 (1971).

    PubMed  CAS  Google Scholar 

  7. C.W. Haidle, K.K. Weiss, and M.T. Kuo, Mol. Pharmacol., 8, 531 (1972).

    PubMed  CAS  Google Scholar 

  8. M.T. Kuo and C.W. Haidle, Biochim. Biophys. Acta, 335, 109 (1974).

    Google Scholar 

  9. W.E.G. Müller, Z. Yamazaki, H.J. Breter, and R.K. Zahn, Eur. J. Biochem., 31, 518 (1972).

    Article  PubMed  Google Scholar 

  10. A. Kono, Y. Matsushima, M. Kojima, and T. Maeda, Chem. Pharm. Bull. (Tokyo), 25, 1725 (1977).

    CAS  Google Scholar 

  11. K. Nagai H. Yamaki H. Suzuki N. Tanaka and H. Umezawa Biochim. Biophys. Acta 179, 165 (1969).

    PubMed  CAS  Google Scholar 

  12. E.A. Sausville, J. Peisach, and S.B. Horwitz, Biochem. Biophys. Res. Commun., 73, 814 (1976).

    Article  PubMed  CAS  Google Scholar 

  13. J.W. Lown and S. Sim, Biochem. Biophys. Res. Commun.,77, 1150 (1977).

    Article  PubMed  CAS  Google Scholar 

  14. I. Shirakawa, M. Azegami, S. Ishii, and H. Umezawa, J. Antibiot. (Tokyo), 24, 761 (1971).

    CAS  Google Scholar 

  15. M. Takeshita, A.P. Grollman, and S.B. Horwitz, Virology,69, 453 (1976).

    Article  PubMed  CAS  Google Scholar 

  16. K. Takahashi, O. Yoshioka, A. Matsuda, and H. Umezawa, J. Antibiot. (Tokyo), 30, 861 (1977).

    CAS  Google Scholar 

  17. H. Suzuki, K. Nagai, H. Yamaki, N. Tanaka, and H. Umezawa, J. Antibiot. (Tokyo), 21, 379 (1968).

    CAS  Google Scholar 

  18. T. Ichikawa, A. Matsuda, K. Miyamoto, M. Tsubosaki, T. Kaihara, K. Sakamoto, and H. Umezawa, J. Antibiot. (Tokyo), 20, 149 (1967).

    CAS  Google Scholar 

  19. M. Ishizuka, H. Takayama, T. Takeuchi, and H. Umezawa, J. Antibiot. (Tokyo),20, 15 (1967).

    CAS  Google Scholar 

  20. H. Umezawa, M. Ishizuka, K. Kimura, J. Iwanaga, and T. Takeuchi, J. Antibiot. (Tokyo), 21, 592 (1968).

    CAS  Google Scholar 

  21. J.C. Dabrowiak, F.T. Greenaway, W.E. Longo, M. vanHusen, and S.T. Crooke, Biochim. Biophys. Acta, 517, 517 (1978).

    PubMed  CAS  Google Scholar 

  22. J.C. Dabrowiak, F.T. Greenaway, and R. Grulich, Biochemistry, 17, 4090(1978).

    Article  PubMed  CAS  Google Scholar 

  23. F.H. Fraser and D.J. Macero, Chem. Instrum.,4, 97 (1972).

    Article  CAS  Google Scholar 

  24. J. Peisach and W.E. Blumburg, Arch. Biochem. Biophys., 165, 691 (1974).

    Article  PubMed  CAS  Google Scholar 

  25. J.C. Dabrowiak, W. E. Longo, and F.S. Santillo, unpublished results.

    Google Scholar 

  26. M. Konishi, K. Saito, K. Numata, T. Tsuno, K. Asama, H. Tsukiura, T. Naito, and H. Kawaguchi, J. Antibiot. (Tokyo), 30, 789 (1977).

    CAS  Google Scholar 

  27. G. Koyama, H. Nakamura, Y. Muraoka, T. Takita, K. Maeda, and H. Umezawa, Tetrahedron Lett., 44, 4635 (1968).

    Article  Google Scholar 

  28. H. Asakura, M. Mori, and H. Umezawa, J. Antibiot. (Tokyo), 28, 537 (1975).

    CAS  Google Scholar 

  29. F.A. Cotton and G. Wilkinson, Advanced Inorganic Chemistry, 3rd ed. Interscience Publishers New York, (1972).

    Google Scholar 

  30. E.J. Billa, Inorg. Nucl. Chern. Lett., 10, 613 (1974).

    Article  Google Scholar 

  31. S.K. Gupta, T.S. Srivastava, J. Inorg. Nucl. Chem., 32, 1611 (1970).

    Article  CAS  Google Scholar 

  32. H. Umezawa, Fed. Proc., 33, 2296 (1974).

    PubMed  CAS  Google Scholar 

  33. H. Naganawa, Y. Muraoka, T. Takita, and H. Umezawa, J. Antibiot. (Tokyo), 30, 388 (1977).

    CAS  Google Scholar 

  34. T.F. Dorigatti and E.J. Billo, J. Inorg. Nucl. Chem., 37, 1515 (1975).

    Article  CAS  Google Scholar 

  35. G.L. Eichhorn, Inorganic Biochemistry, Elsevier, New York (1973).

    Google Scholar 

  36. J.C. Dabrowiak and F.S. Santillo, unpublished results.

    Google Scholar 

  37. S. Koch, R.H. Holm, and R.B. Frankel, J. Am. Chern. Soc., 97, 6714 (1975).

    Article  CAS  Google Scholar 

  38. B.R. McGarvey, Trans. Metal Chem., 3, 90 (1966).

    Google Scholar 

  39. W.E. Blumberg, In Magnetic Resonance in Biological Systems (A. Ehrenberg, B. E. Malmstrom, and T. Vanngard, Eds.), p.119. Pergamon Press, London (1967).

    Google Scholar 

  40. E.G. Janzen, D.E. Nutter, Jr., E.R. Davis, B.J. Blackburn, J.L. Poyer, and P.B. McCay, Can. J. Chem., 56, 2237 (19780).

    Article  CAS  Google Scholar 

  41. J. Peisach and W.E. Blumberg, Adv. Chern. Ser., 100, 271 (1971).

    Google Scholar 

  42. S.G. Mairanovskii, J. Electroanal. Chem., 6, 77 (1963).

    Article  CAS  Google Scholar 

  43. B. Janik and P.J. Elving, Chem. Rev., 68, 295 (1968).

    Article  PubMed  CAS  Google Scholar 

  44. D.L. Smith and P.J. Elving, J. Am. Chem. Soc., 84, 2741 (1962).

    Article  CAS  Google Scholar 

  45. M. Chien, A.P. Grollman, and S.B. Horwitz, Biochemistry, 16, 364 (1977).

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Dabrowiak, J., Greenway, F., Santillo, F. (1979). Erratum to: The Metallobleomycins. In: Hect, S.M. (eds) Bleomycin: Chemical, Biochemical, and Biological Aspects. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-6191-9_31

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-6191-9_31

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-6193-3

  • Online ISBN: 978-1-4612-6191-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics